Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BLSH compared with CRSP: revenue, margins and what each company keeps, and the suppliers and customers both name
BLSH
Bullish
Change
Mkt cap
Revenue
Revenue
CRSP
CRISPR Therapeutics AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
BLSH
Bullish
vs
CRSP
CRISPR Therapeutics AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BLSH
No earnings history for BLSH.
CRSP
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±7.8%
▲
+7.06%
×0.91
Q1 FY26
±5.9%
▼
−2.24%
×0.37
Feb 13 '26
±3.6%
▲
+8.46%
×2.36
Q3 FY25
±8.4%
▼
−0.98%
×0.12
= implied
BLSH realized, solid
CRSP realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
BLSH
Bullish
Change
22.51
▼
−5.83%
· post 22.56
Mkt cap
$3.4B
Revenue
—
Revenue
—
CRSP
CRISPR Therapeutics AG
Change
49.98
▼
−2.80%
· post 49.76
Closed
Nov 2 '26
Mkt cap
$5.0B
Revenue
$13M
Q3 FY26
Revenue
$4M
FY25
vs
Compare
Closed
Nov 2 '26
BLSH
Bullish
vs
CRSP
CRISPR Therapeutics AG
22.51
▼
−5.83%
post 22.56
Price
49.98
▼
−2.80%
post 49.76
$3.4B
Mkt cap
$5.0B
—
Revenue
$13M
Q3 FY26
—
Revenue
$4M
FY25
Change
Change
BLSH
22.51
▼
−5.83%
vs
CRSP
49.98
▼
−2.80%
Closed
Nov 2 '26